Figure 2From: The Belgian MIRA (MabThera In Rheumatoid Arthritis) registry: clues for the optimization of rituximab treatment strategiesProportions of patients in each disease activity score category at baseline, week 16, and week 24 of courses 1 and 2. Four hundred one patients started rituximab treatment. Second and third courses were given in 224 and 104 patients, respectively. DAS28, disease activity score using 28 joint counts.Back to article page